MS Speaks

Multiple Sclerosis => TREATMENTS => LEMTRADA (Campath, alemtuzumab) => Topic started by: agate on April 10, 2019, 04:24:57 pm

Title: (Abst.) Immune profiling of a patient w/alemtuzumab-associated PML
Post by: agate on April 10, 2019, 04:24:57 pm

From PubMed (April 10, 2019), "Immune profiling of a patient w/alemtuzumab-associated PML":


http://bit.ly/2IdR0WO